Page 2513 - Hematology_ Basic Principles and Practice ( PDFDrive )

2237.e8 Part XII Hemostasis and Thrombosis

332. Valentini RP, Imam A, Warrier I, et al: Sirolimus rescue for tacrolimus- 356. Malouf MA, Milliken S, Glanville AR: Successful management of
associated post-transplant autoimmune hemolytic anemia. Pediatr profound thrombocytopenia after lung and heart-lung transplantation.
Transplant 10(3):358–361, 2006. J Heart Lung Transplant 19(6):612–614, 2000.
333. Kitamura T, Mizuta K, Kawarasaki H, et al: Severe hemolytic anemia 357. Rawal A, Sarode R, Curtis BR, et al: Acquired Glanzmann’s thrombas-
related to production of cold agglutinins following living donor liver thenia as part of multiple-autoantibody syndrome in a pediatric heart
transplantation: a case report. Transplant Proc 35(1):399–400, 2003. transplant patient. J Pediatr 144(5):672–674, 2004.
334. Lacaille F, Moes N, Hugot JP, et al: Severe dysimmune cytopenia in 358. West KA, Anderson DR, McAlister VC, et al: Alloimmune thrombocy-
children treated with tacrolimus after organ transplantation. Am J topenia after organ transplantation. N Engl J Med 341(20):1504–1507,
Transplant 6(5 Pt 1):1072–1076, 2006. 1999.
335. Tubman VN, Smoot L, Heeney MM: Acquired immune cytopenias 359. Singh N, Carrigan DR: Human herpesvirus-6 in transplantation: an
post-cardiac transplantation respond to rituximab. Pediatr Blood Cancer emerging pathogen. Ann Intern Med 124(12):1065–1071, 1996.
48(3):339–344, 2007. 360. Feldstein AE, Razonable RR, Boyce TG, et al: Prevalence and clinical
336. Li M, Goldfinger D, Yuan S: Autoimmune hemolytic anemia in significance of human herpesviruses 6 and 7 active infection in pediatric
pediatric liver or combined liver and small bowel transplant patients: a liver transplant patients. Pediatr Transplant 7(2):125–129, 2003.
case series and review of the literature. Transfusion 52:48, 2012. 361. Yoshikawa T, Ihira M, Suzuki K, et al: Human herpesvirus 6 infection
337. Riechsteiner G, Speich R, Schanz U, et al: Haemolytic anaemia after after living related liver transplantation. J Med Virol 62(1):52–59, 2000.
lung transplantation: an immune-mediated phenomenon? Swiss Med 362. Trachtman H, Weiss RA, Spigland I, et al: Clinical manifestations of
Wkly 133(9–10):143–147, 2003. herpesvirus infections in pediatric renal transplant recipients. Pediatr
338. Peter C, Latta K, Graf D, et al: Does tacrolimus cause more severe Infect Dis 4(5):480–486, 1985.
anemia than cyclosporine A in children after renal transplantation? 363. Arakawa Y, Matsui A, Sasaki N, et al: Agranulocytosis and thrombocy-
Transpl Int 11(Suppl 1):S328–S330, 1998. topenic purpura following measles infection in a living-related ortho-
339. Eid AJ, Brown RA, Patel R, et al: Parvovirus B19 infection after topic liver transplantation recipient. Acta Paediatr Jpn 39(2):226–229,
transplantation: a review of 98 cases. Clin Infect Dis 43(1):40–48, 2006. 1997.
340. Broliden K: Parvovirus B19 infection in pediatric solid-organ and bone 364. Trindade E, Maton P, Reding R, et al: Use of granulocyte macrophage
marrow transplantation. Pediatr Transplant 5(5):320–330, 2001. colony stimulating factor in children after orthotopic liver transplanta-
341. Ben Hamida C, Lauzet JY, Rezaiguia-Delclaux S, et al: Effect of severe tion. J Hepatol 28(6):1054–1057, 1998.
thrombocytopenia on patient outcome after liver transplantation. 365. Peddi VR, Hariharan S, Schroeder TJ, et al: Role of granulocyte colony
Intensive Care Med 29(5):756–762, 2003. stimulating factor (G-CSF) in reversing neutropenia in renal allograft
342. Chang FY, Singh N, Gayowski T, et al: Thrombocytopenia in liver recipients. Clin Transplant 10(1 Pt 1):20–23, 1996.
transplant recipients: predictors, impact on fungal infections, and role 366. Turgeon N, Hovingh GK, Fishman JA, et al: Safety and efficacy of
of endogenous thrombopoietin. Transplantation 69(1):70–75, 2000. granulocyte colony-stimulating factor in kidney and liver transplant
343. Chatzipetrou MA, Tsaroucha AK, Weppler D, et al: Thrombocytopenia recipients. Transpl Infect Dis 2(1):15–21, 2000.
after liver transplantation. Transplantation 67(5):702–706, 1999. 367. Chitlur M, Abella E, Singh TP, et al: Severe neutropenia and thrombo-
344. Peck-Radosavljevic M, Wichlas M, Zacherl J, et al: Thrombopoietin cytopenia following cardiac transplantation in a child. Pediatr Transplant
induces rapid resolution of thrombocytopenia after orthotopic 9(1):94–96, 2005.
liver transplantation through increased platelet production. Blood 368. Moghal NE, Milford DV, Darbyshire P: Treatment of neutropenia in
95(3):795–801, 2000. a renal transplant recipient with granulocyte colony-stimulating factor.
345. Richards EM, Alexander GJ, Calne RY, et al: Thrombocytopenia fol- Pediatr Nephrol 12(1):14–15, 1998.
lowing liver transplantation is associated with platelet consumption and 369. Oak NR, Triulzi DJ: Granulocyte transfusion therapy in abdominal
thrombin generation. Br J Haematol 98(2):315–321, 1997. organ transplant recipients. J Clin Apher 24(5):186–189, 2009.
346. Honda M, Yamamoto H, Hayashida S, et al: Factors predicting per- 370. Schutz E, Gummert J, Mohr FW, et al: Should 6-thioguanine nucleo-
sistent thrombocytopenia after living donor liver transplantation in tides be monitored in heart transplant recipients given azathioprine?
pediatric patients. Pediatr Transplant 15(6):601–605, 2011. Ther Drug Monit 18(3):228–233, 1996.
347. Sutedja DS, Wai CT, Teoh KF, et al: Persistent thrombocytopenia in 371. Bergan S, Rugstad HE, Bentdal O, et al: Monitored high-dose azathio-
liver transplant patients. Transplant Proc 36(8):2331–2333, 2004. prine treatment reduces acute rejection episodes after renal transplanta-
348. Masterson R, Leikis M, Perkovic V, et al: Sirolimus: a single center tion. Transplantation 66(3):334–339, 1998.
experience in combination with calcineurin inhibitors. Transplant Proc 372. Schutz E, Gummert J, Armstrong VW, et al: Azathioprine phar-
35(3 Suppl):99S–104S, 2003. macogenetics: the relationship between 6-thioguanine nucleotides
349. Chang GJ, Mahanty HD, Quan D, et al: Experience with the use of and thiopurine methyltransferase in patients after heart and kidney
sirolimus in liver transplantation—use in patients for whom calcineurin transplantation. Eur J Clin Chem Clin Biochem 34(3):199–205,
inhibitors are contraindicated. Liver Transpl 6(6):734–740, 2000. 1996.
350. Hymes LC, Warshaw BL: Sirolimus in pediatric patients: results in the 373. Shapiro R, Jordan ML, Scantlebury VP, et al: A prospective, random-
first 6 months post-renal transplant. Pediatr Transplant 9(4):520–522, ized trial to compare tacrolimus and prednisone with and without
2005. mycophenolate mofetil in patients undergoing renal transplantation:
351. Hong JC, Kahan BD: Sirolimus-induced thrombocytopenia and leuko- first report. J Urol 160(6 Pt 1):1982, 1998.
penia in renal transplant recipients: risk factors, incidence, progression, 374. Kennedy GA, Kay TD, Johnson DW, et al: Neutrophil dysplasia char-
and management. Transplantation 69(10):2085–2090, 2000. acterised by a pseudo-Pelger-Huet anomaly occurring with the use of
352. Meier-Kriesche HU, Kaplan B: Toxicity and efficacy of sirolimus: rela- mycophenolate mofetil and ganciclovir following renal transplantation:
tionship to whole-blood concentrations. Clin Ther 22(SupplB):B93– a report of five cases. Pathology 34(3):263–266, 2002.
B100, 2000. 375. Nogueras F, Espinosa MD, Mansilla A, et al: Mycophenolate
353. Babinska A, Markell MS, Salifu MO, et al: Enhancement of human mofetil-induced neutropenia in liver transplantation. Transplant Proc
platelet aggregation and secretion induced by rapamycin. Nephrol Dial 37(3):1509–1511, 2005.
Transplant 13(12):3153–3159, 1998. 376. Danziger-Isakov L, Mark Baillie G: Hematologic complications of
354. Taylor RM, Bockenstedt P, Su GL, et al: Immune thrombocytopenic anti-CMV therapy in solid organ transplant recipients. Clin Transplant
purpura following liver transplantation: a case series and review of the 23(3):295–304, 2009.
literature. Liver Transpl 12(5):781–791, 2006. 377. Royer B, Zanetta G, Berard M, et al: A neutropenia suggesting an
355. Rosoff PM, Tuttle-Newhall E, Treem WR: Successful treatment of interaction between valacyclovir and mycophenolate mofetil. Clin
immune thrombocytopenic purpura with anti-D antibody following Transplant 17(2):158–161, 2003.
a cadaveric liver transplant for hepatoblastoma. Med Pediatr Oncol 378. Molina Perez E, Fernández Castroagudin J, Seijo Ríos S, et al:
40(6):402–404, 2003. Valganciclovir-induced leukopenia in liver transplant recipients: